These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33146712)

  • 1. Transcription factor Sp1 is upregulated by PKCι to drive the expression of YAP1 during pancreatic carcinogenesis.
    Yang J; Wang J; Zhang H; Li C; Chen C; Zhu T
    Carcinogenesis; 2021 Apr; 42(3):344-356. PubMed ID: 33146712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-KRAS attenuates Hippo signaling pathway through PKCι to sustain the growth of pancreatic cancer.
    Wang P; Zhang H; Yang J; Li Z; Wang Y; Leng X; Ganapathy S; Isakson P; Chen C; Zhu T
    J Cell Physiol; 2020 Jan; 235(1):408-420. PubMed ID: 31230347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma.
    Ito M; Codony-Servat C; Codony-Servat J; Lligé D; Chaib I; Sun X; Miao J; Sun R; Cai X; Verlicchi A; Okada M; Molina-Vila MA; Karachaliou N; Cao P; Rosell R
    Cell Commun Signal; 2019 Oct; 17(1):137. PubMed ID: 31660987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.
    Gruber R; Panayiotou R; Nye E; Spencer-Dene B; Stamp G; Behrens A
    Gastroenterology; 2016 Sep; 151(3):526-39. PubMed ID: 27215660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
    Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP
    Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential.
    Zhang J; Wong CC; Leung KT; Wu F; Zhou Y; Tong JHM; Chan RCK; Li H; Wang Y; Yan H; Liu L; Wu WKK; Chan MWY; Cheng ASL; Yu J; Wong N; Lo KW; To KF; Kang W
    Oncogene; 2020 Oct; 39(43):6647-6663. PubMed ID: 32934314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer.
    Zhao X; Wang X; Fang L; Lan C; Zheng X; Wang Y; Zhang Y; Han X; Liu S; Cheng K; Zhao Y; Shi J; Guo J; Hao J; Ren H; Nie G
    Cancer Lett; 2017 Aug; 402():61-70. PubMed ID: 28576749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKCι and YAP1 are crucial in promoting pancreatic tumorigenesis.
    Wang P; Wei D; Zhang H; Chen J; Zhang D; Ganapathy S; Isakson P; Chen C; Zhu T
    Oncotarget; 2018 Aug; 9(67):32736-32750. PubMed ID: 30214681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Ben Q; An W; Sun Y; Qian A; Liu J; Zou D; Yuan Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):181. PubMed ID: 32894161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity.
    Jia Z; Gao Y; Wang L; Li Q; Zhang J; Le X; Wei D; Yao JC; Chang DZ; Huang S; Xie K
    Cancer Res; 2010 Feb; 70(3):1111-9. PubMed ID: 20086170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis.
    Gao Y; Jia Z; Kong X; Li Q; Chang DZ; Wei D; Le X; Suyun H; Huang S; Wang L; Xie K
    Cancer Res; 2011 Aug; 71(15):5182-93. PubMed ID: 21673052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
    Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
    Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.
    Wu DW; Wang YC; Wang L; Chen CY; Lee H
    Theranostics; 2018; 8(5):1256-1269. PubMed ID: 29507618
    [No Abstract]   [Full Text] [Related]  

  • 14. miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells.
    Xu X; Chen X; Xu M; Liu X; Pan B; Qin J; Xu T; Zeng K; Pan Y; He B; Sun H; Sun L; Wang S
    Aging (Albany NY); 2019 Sep; 11(18):7357-7385. PubMed ID: 31543507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.
    Scotti ML; Bamlet WR; Smyrk TC; Fields AP; Murray NR
    Cancer Res; 2010 Mar; 70(5):2064-74. PubMed ID: 20179210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota.
    Guo W; Wu S; Liu J; Fang B
    Cancer Res; 2008 Sep; 68(18):7403-8. PubMed ID: 18794128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKCι regulates the expression of PDL1 through multiple pathways to modulate immune suppression of pancreatic cancer cells.
    Zhang H; Zhu Y; Wang J; Weng S; Zuo F; Li C; Zhu T
    Cell Signal; 2021 Oct; 86():110115. PubMed ID: 34375670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.
    Wei D; Wang L; He Y; Xiong HQ; Abbruzzese JL; Xie K
    Cancer Res; 2004 Mar; 64(6):2030-8. PubMed ID: 15026340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development.
    Rozengurt E; Eibl G
    World J Gastroenterol; 2019 Apr; 25(15):1797-1816. PubMed ID: 31057295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma.
    Kim KH; Chung C; Kim JM; Lee D; Cho SY; Lee TH; Cho HJ; Yeo MK
    BMC Cancer; 2019 Aug; 19(1):804. PubMed ID: 31412817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.